Genetics. PCR. Thrombophilia (Determination of genetic polymorphisms)

2,200 UAH

Genetic studies/Blood clotting function studies

Indicators:

  • Gene F5 (1691 G>A) Coagulation Factor V (Leiden Mutation)
  • Gene F2 (20210 G>A ) Prothrombin or blood clotting factor II
  • Gene F7 (10976 G>A) Coagulation factor VII (proconvertin, or convertin)
  • Gene F13 (G>T) Coagulation factor XIII (fibrinase)
  • FGB gene (455 G>A) Blood clotting factor I (fibrinogen)
  • ITGA2 gene (807 C>T) α2 integrin (platelet receptor for collagen)
  • ITGB3 gene (1565 T>C) β3 integrin (platelet receptor for fibrinogen)
  • SERPINE1 gene, PAI-1 (675 5G>4G) Tissue plasminogen activator antagonist

Products that will be added:

  • Blood collection with disposable Vacuette, BD Vacutainer systems
Description
4.9/5 - (1375 votes)

Genetics is the science that studies heredity and variation in organisms. Genetic research helps to understand how hereditary factors affect various aspects of health, including susceptibility to certain diseases. One important method used in genetic research is the polymerase chain reaction (PCR). PCR allows you to amplify (increase the number of) certain fragments of DNA, which makes it indispensable in the diagnosis and study of genetic diseases.

Thrombophilia: what is it?

Thrombophilia is a condition in which a person is at increased risk of developing blood clots (thrombi) in the blood vessels. This can lead to serious complications such as heart attack, stroke, deep vein thrombosis, or pulmonary embolism. Thrombophilia can be inherited or acquired, and genetic testing is used to identify genetic polymorphisms that increase the risk of thrombosis.

Genetic polymorphisms associated with thrombophilia

Genetic polymorphisms are variations in the DNA sequence that can affect gene function. Some of these polymorphisms are associated with an increased risk of thrombophilia. The most well-known of these are:

  1. Factor V Leiden (F5) is a mutation in the coagulation factor V gene that increases the risk of venous thrombosis.
  2. Prothrombin mutation (F2) is a mutation in the prothrombin gene, which also increases the risk of thrombosis.
  3. Mutations in the MTHFR genes – these mutations affect folate metabolism and may increase the risk of thrombosis due to elevated homocysteine levels in the blood.

Blood clotting function studies

To diagnose thrombophilia, a number of genetic tests are performed to detect these mutations. Here are the main steps in this process:

  1. Sample collection – a blood or saliva sample is usually taken for testing.
  2. DNA extraction – DNA is extracted from the sample.
  3. DNA amplification using PCR – PCR is used to determine the presence of specific mutations, which allows you to increase the number of necessary DNA fragments.
  4. Analysis of results – the obtained DNA fragments are analyzed for the presence of genetic polymorphisms.

The importance of genetic research

  1. Early risk detection – genetic studies allow us to identify a predisposition to thrombophilia before the first symptoms appear, which allows us to take preventive measures.
  2. Individualized treatment – knowledge about genetic polymorphisms allows doctors to select the most effective methods of treatment and prevention.
  3. Family planning – information about genetic risks is important for family planning, especially if there are already cases of thrombophilia in the family.

Genetic testing plays an important role in the diagnosis of thrombophilia. The use of polymerase chain reaction (PCR) to identify genetic polymorphisms allows for early identification of risks and the development of effective prevention and treatment strategies. This is particularly important for reducing the risk of serious complications associated with thrombophilia and ensuring the health and well-being of patients.

Additional information
Execution time

1 day

Type of biomaterial

Blood